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ABSTRACT 
Background and aims: PCOS (polycystic ovary syndrome) is the most common 
endocrine and metabolic disorder characterized by amenorrhea, hyper androgens, 
hirsutism, chronic anovulation and infertility. The aim of the present study was 
determining the effects of ginger extract, and 6-gingerol on hormonal levels and ovarian 
follicles in induced PCOS rats, and comparing the ameliorating effects of these two 
substances for treatment of PCOS. 
Methods: In this experimental research, 42 adult female Wistar rats weighting between 
160 g-180 g were divided into six groups of 7 animals. PCOS control that received no 
injection. PCOS received intraperitoneal injections of 100 mg/kg of ginger extract (for  
28 days). Statistical analyses with SPSS, one-way ANOVA, T-test and Duncan test were 
used to compare groups. 
Results: In comparison with PCOS control, the treatment of PCOS rats with ginger 
extract (100 and 200 mg/kg) and 6-gingerol (200 and 400 µg/kg) led to significant 
decrease in LH levels. There was a decrease in FSH levels, but the significant one was 
only in the 6-gingerol treated group (400 µg/kg). In PCOS treated groups with ginger 
extract and 6-gingerol, the serum levels of estradiol decreased significantly compared to 
control and PCOS control groups (P<0.001). Progesterone levels in PCOS groups 
injected with ginger extract and 6-gingerol showed a significant increase (P<0.05). In 
PCOS treated groups with ginger extract and 6-gingerol, testosterone levels decreased 
significantly (P<0.001, P<0.01, P<0.05). 
Conclusion: 6-gingerol and ginger extract may be a useful treatment for improving the 
PCOS through reduction of estrogen, testosterone, LH and FSH, and improvement of 
ovulation. In fact, because of anti-inflammatory and antioxidant properties of ginger 
components, especially 6-gingerol, they can cause to improve PCOS. 
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INTRODUCTION 
PCOS (polycystic ovary syndrome) is 
the most common endocrine and metabolic 
disorder characterized by amenorrhea, hyper 
androgens, hirsutism, chronic anovulation 
and infertility. In this syndrome, ovarian 
morphological abnormalities such as 
polycystic ovaries with small ovarian 
follicles producing predominantly androgens 
in thecal cells consider. 
All PCOS women are at risk of insulin 
resistance, metabolic syndrome, endometrial 
hyperplasia and cardiovascular diseases. The 
exact etiology of PCOS is not entirely clear, 
although hypersecretion of LH and insulin 
resistance are known to be responsible for  
the pathogenesis of the syndrome. In  
PCOS women, insulin resistance and 
subsequent hyperinsulinemia may contribute 
to hyperandrogenism and abnormal 
gonadotropin levels.
1,2
 
Ginger is the rhizomes of the plant 
Zingiber officinale belonging to the family 
zingiberaceae and has been cultivated for a 
thousand years as a cooking spice and 
flavoring agent in many Asian and African 
countries. Moreover, ginger possesses 
medical properties and widely used in the 
treatment of various disorders including 
headaches, vomiting, asthma, rheumatism, 
arthritis, gastrointestinal disturbances  
and diabetes. In addition, anti-tumor,  
anti-inflammation, anti-hepatotoxicity and 
anti-microbial properties that have been 
shown in recent.
3,4
 The mechanism of 
chemo preventive effects of ginger is 
attributed to its antioxidant activities, free 
radical scavenging, alteration of gene 
expressions and induction of apoptosis 
resulting decrease in tumor promotion and 
progression.
5
 6-Gingerol is one of the major 
components of ginger which is responsible 
for its pungent taste (Figure 1), as well  
as ginger's most anti-oxidative and  
anti-inflammatory component.
6 
 
Figure 1: Chemical structure of 6-gingerol 
 
Infertility is a widespread medical 
problem, defined as the inability to 
conceive without contraception after one 
year of regular intercourse. Approximately 
30% of infertilities are due to female 
fertility problems. The most common 
causes of female infertility are ovulation 
problems often caused by PCOS. In fact, 
this is a disorder with hormonal imbalance 
affecting the normal ovulation.
7
 Given the 
importance of the infertility treatment and 
the main role of PCOS in the pathogenesis 
of anovulation and infertility, the aim of 
the present study was determining the 
effects of ginger extract, and 6-gingerol on 
hormonal levels and ovarian follicles in 
induced PCOS rats, and comparing the 
ameliorating effects of these two 
substances for treatment of PCOS. 
 
METHODS 
Estradiol valerate and 6-Gingerol were 
purchased from Abraham Co. (Iran) and 
Sigma- Aldrich Co. (USA), respectively. Rat 
Estradiol and Progesterone ELISA kits were 
purchased from Monobind Co. (USA), and 
serum concentration of Testosterone, FSH 
and LH were measured using rat/mouse 
testosterone, FSH and LH ELISA kits from 
Cosmo Bio Co. (Japan). 
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42 adult female Wistar rats weighting 
between 160 g-180 g were purchased from 
the Pasteur Institute of Tehran, Iran. The rats 
were kept in temperature controlled room 
(23 °C), exposed to a 12-hour light/dark 
cycle, and they fed with normal diet and 
sufficient water. To adapt to the environment, 
the rats were kept under the above conditions 
for 14 days. To control, regular estrous cycle, 
daily vaginal smear was prepared for  
2 weeks. After 14 days of acclimatization, the 
rats were divided into 6 groups of control and 
PCOS treated groups. 
The rats were divided into 6 groups of  
7 animals as follows: Group C: Control 
without treatment. PCOS control that  
received no injection. Group PCOS-G100: 
PCOS received intraperitoneal injections of 
100 mg/kg of ginger extract (for 28 days); 
Group PCOS-G200: PCOS received 
intraperitoneal injections of 200 mg/kg  
of ginger extract (for 28 days); Group  
PCOS-6g200: PCOS received intraperitoneal 
injections of 200 µg/kg of 6-gingerol (for  
14 days); Group PCOS-6g400: PCOS received 
intraperitoneal injections of 400 µg/kg of  
6-gingerol (for 14 days). 
4 mg estradiol valerate (EV) in 0.4 ml 
oil/rat is injected subcutaneously for  
28 days. To confirm the induction of 
syndrome at the end of injection course, 
blood samples was taken via heart puncture 
and two rats of PCOS group were sacrificed, 
then, hormonal and morphological studies 
were performed. 
The fresh rhizomes of ginger were 
purchased from the local markets of Tehran, 
Iran. The ginger rhizomes were cleaned, 
washed, dried at room temperature and 
powdered by electric grinder. To prepare 
hydro-alcoholic extract, 150 grams of ginger 
powder were soaked with 1500 ml of 70% 
ethanol in the Soxhlet apparatus for 48 
hours. Then the rotary evaporator was used 
to concentrate and dry the extract. 
Afterwards, in order to dissolve the extract 
and prepare the specified concentrations 
distilled water was used. 6-gingerol also was 
dissolved in distilled water to prepare 
treatment doses. 
At the end of treatment duration, the rats 
were anaesthetized and blood samples were 
taken via heart puncture. To separate the 
serum, blood samples were allowed to clot 
and centrifuged at 12000 RPM for 5 min.  
The serum concentrations of estradiol, 
progesterone, testosterone, LH and FSH were 
measured by ELISA kits according to the 
manufacturer’s instruction. 
Ovaries were dissected apart and fixed 
in 10% formaldehyde. The fixed samples 
were kept in alcohol solutions for 
dehydration and cleared in xylene, and then 
embedded in paraffin. The samples were 
sectioned serially in 7 micron thickness by 
microtome and finally stained with 
hematoxylin and eosin. 
Statistical analyses with SPSS, one-way 
ANOVA, T-test and Duncan test were used 
to compare groups (P<0.05). The results 
were expressed as the mean ± standard 
deviation (SD). Finally, graphs were plotted 
by Excel software. 
 
RESULTS 
In PCOS control group, the LH, FSH, 
estradiol and testosterone hormones showed a 
significant increase compared to control 
group (P<0.01). Progesterone levels decrease 
in the PCOS group compared to control 
group, but this reduction was not significant. 
Histological studies showed that, in the 
PCOS control group the number of corpora 
lutea decreased, and the number of cystic 
follicles, increased significantly, while in the 
control group the ovaries were lacking cystic 
follicles, and possessed a great number of 
corpora lutea. These observations indicated 
that EV injection led to decrease in the 
number of active follicles and subsequently 
decreased ovulation (Figure 2). 
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Figure 2: The macroscopic (A) and microscopic (B) 
View of rat ovary, that induced by subcutaneous injection of EV. Increase of cystic follicles (CF) and decrease of 
corpus luteum is observed. The ovary sections were stained by haematoxylin and eosin. 
 
In comparison with PCOS control, the 
treatment of PCOS rats with ginger extract 
(100 and 200 mg/kg) and 6-gingerol (200 and 
400 µg/kg) led to significant decrease in LH 
levels. There was a decrease in FSH levels, 
but the significant one was only in the  
6-gingerol treated group (400 µg/kg). In 
PCOS treated groups with ginger extract and 
6-gingerol, the serum levels of estradiol 
decreased significantly compared to control 
and PCOS control groups (P<0.001). 
Progesterone levels in PCOS groups injected 
with ginger extract and 6-gingerol showed a 
significant increase (P<0.05). In PCOS treated 
groups with ginger extract and 6-gingerol, 
testosterone levels decreased significantly 
(P<0.001, P<0.01, P<0.05). These results have 
shown in Table 1. 
 
Table 1: The values of estradiol, progesterone, testosterone, LH and FSH in the studied groups 
Groups E2 (ng/ml) P4 (ng/ml) T (ng/ml) LH (ng/ml) FSH (ng/ml) 
Control 0.0386±0.003 2.29±0.015 3.1±0.1 3.24±0.41 18±1.62 
PCOS control 0.0465±0.004 (+++) 2.12±0.181 4±0.26 (+++) 4.27±0.83(+++) 22.5±2.43(+++) 
PCO-G100 0.0461±0.003 (+++) 2.25±0.056 3.83±0.11 (+++) 3.95±0.66(+++) 21.15±1.89 
PCO-G200 0.0451±0.001 (+++) 2.24±0.0137 3.8±0.1 (+++) 3.78±0.42(+++) 20.27±1.13 
PCO-6g200 0.0430±0.005 (+++**) 2.34±0.076 3.6±0.1 (+++*) 3.73±0.55 (+++***) 18.45±1.62(**) 
PCO-6g400 0.404±0.002(***) 2.48±0.036 (***) 3.36±0.15 (***) 3.55±0.6(***) 17.1±1.67(***) 
Values are Mean ± Standard deviation (Mean ± SD); PCOS induction led to a significant increase in FSH, LH, E2 
and T versus control rats; These treatments led to a significant decrease in T, E2, FSH and LH, also a significant 
increase in P4 levels in PCOS treated groups, compare to PCOS control group. E2: Estradiol, P4: Progesterone,  
T: Testosterone, LH: Luteinizing hormone, FSH: Follicle stimulating hormone; +: P<0.05, ++: P<0.01,  
+++: p<0.001; Differences between PCOS control group and PCOS treated groups with the control group.  
*: P<0.05, **: P<0.01, ***: P<0.001; Differences between PCOS treated groups with ginger extract and  
6-gingerol and PCOS control group. 
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In PCOS groups treated with ginger 
extract and 6-gingerol, the number of 
ovarian cysts showed a significant decrease 
compared to PCOS control group which 
means no cysts were observed in PCOS 
groups treated with doses of 6-gingerol  
(200 and 400 µg/kg). Comparing to PCOS 
control, moreover, the number of primary, 
preantral, antral follicles as well as corpus 
luteum increased in PCOS treated groups 
with ginger extract and 6-gingerol. 
Therefore, these changes indicated relative 
improvement of ovarian function in PCOS 
treated groups (Figure 3). 
 
 
 
Figure 3: Diagrammatic comparison of follicles in control, PCOS control and PCOS treated 
groups with ginger extract and 6-gingerol 
PMF: Primordial follicle; PF: Primary follicle; PAF: Parenteral follicle; AF: Antral follicle; CL: Corpus luteum; 
CF: Cystic follicle; A: Differences between PCOS group and control group; B: Differences between PCOS treated 
groups with ginger extract and 6-gingerol, and PCOS control group. *: P<0.05, **: P<0.01, ***: P<0.001. 
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DISCUSION
In this research, PCOS was induced in 
adult female Wistar rats by intraperitoneal 
injection of EV for 28 days. Data showed 
that after induction of PCOS, serum 
testosterone, estradiol, FSH and LH levels 
increased, while progesterone levels were 
decreased in the PCOS groups compared to 
those in control. Microscopic studies 
showed an increase in the number of cystic 
follicles and a decrease in corpora lutea in 
polycystic ovaries. These findings also 
corroborated with the findings of Kargar 
Jahromi et al, Ghafurniyan et al and Zafari 
et al.
8-10
 
In PCOS groups, the elevated LH levels 
are explained by an increased pituitary 
sensitivity to hypothalamic gonadotropin 
releasing hormone (GnRH), and increased 
pulse frequency of GnRH which may cause 
the production of LH over the FSH.
11
 
Increasing amount of insulin in PCOS lead 
to the decrease of liver production of two 
important proteins: Insulin-like growth 
factor–binding proteins (IGFBP I, II) and 
Sex hormone binding globulin (SHBG) and 
consequently led to an increase in the 
concentrations of IGF I, II and sex steroid 
level, thus IGF I and II augment androgen 
production by LH  stimulation via ovarian 
IGF receptors. On the other hand, a decrease 
of SHBG led to an increase of free estradiol. 
The excess of estrogen in PCOS is also 
caused by peripheral conversion of 
androgens to estrogens, especially by fat 
tissue. In addition,  increased levels of LH 
lead to an increase in the production of 
androgens from the theca cells.
12,13
 In fact 
the LH stimulation caused the thickness of 
the theca cell layer leading to androgen 
hypersecretion by increasing the expression 
of the key enzymes in androgen synthesis. In 
addition, elevated insulin levels are common 
in PCOS bringing about an increase in  
LH-stimulated androgen production in 
polycystic ovaries.
14
 According to the 
previous studies, it was stated that in PCOS 
women, high levels of FSH caused to form 
the ovarian cysts, in fact, elevated androgens 
in this condition lead to increase in GnRH 
neurons activities via the changes in gamma 
amino butyric acid ergic (GABA ergic) 
transmission and finally causes to increase 
of FSH secretion from pituitary.
15,16
 
Low serum progesterone levels in 
PCOS were associated with reduction of 
corpora lutea because the follicles don’t 
release the egg and become cysts in these 
ovaries.
17
 In polycystic ovaries, the number 
of antral follicles is lower than normal 
ovaries. In fact, there is a positive 
correlation between high levels of androgen 
and preventing small follicles to become 
mature.These high androgen levels and 
follicular cell stimulation by LH and insulin 
might produce high levels of cyclic 
adenosine monophosphate (CAMP) in the 
granulosa cells, which causes premature 
terminal differentiation and arrest follicular 
growth.
18
 The serum concentrations of FSH, 
LH, estradiol and testosterone in the PCOS 
groups treated with ginger extract and  
6-general show significant decrease 
compared to PCOS control group; however, 
the level of progesterone significantly 
increased in the PCOS treated groups. 
The obtained results showed reduction 
in the number of ovarian cysts, and increase 
in corpora lutea and antral follicles. It's 
worthy to mention that all changes in this 
research were dose dependent, and the 
effects of 6-gingerol treatment in 
comparison to ginger extract were more 
significant in all parameters. The reason 
which can be stated for a decrease of 
gonadotropins by ginger extract and  
6-gingerol is that ginger and its compounds 
reduce the secretion of FSH and LH via an 
effect on pituitary-gonadal axis.
19
 Researchers 
suggested that gingerols and sesquiterpens 
in ginger via inhibition of cyclooxygenase 
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and lipooxygenase pathways cause to 
inhibition of the arachidonic acid and 
prostaglandin synthesis. Considering the 
role of prostaglandins in gonadotropin 
synthesis, gingerol can decrease 
gonadotropin levels in this way.
20,21
 Other 
studies showed that, due to its action as a 
serotonin receptor antagonist, ginger can 
decrease the secretion of gonadotropin. 
Previous studies indicated that serotonin 
mediates the secretion of GnRH by direct 
stimulation of hypothalamus to release 
GnRH through the phospholipase C (PLC) 
pathway.
22
 On the other hand, many studies 
showed that GABA regulation of GnRH 
neurons affects the regulation of LH surge.
15
 
Many studies showed that some flavonoids 
bind to the benzodiazepine site of the 
GABAA receptor.
23,24
 Thus we can say the 
flavonoids of ginger act as GABA receptor 
agonists, and cause to a decrease in LH 
secretion. Ginger and its active components 
like 6-gingerol cause to decrease in 
testosterone levels via reduction of blood 
glucose and insulin levels, and also through 
the decrease of LH levels and changes in 
pituitary-ovaries axis.
25
 Biosynthesis of 
estrogens from androgens are done by 
Aromatase enzyme. In fact, Aromatase is a 
cytochrome P450 enzyme, and inhibited by 
6-gingerol causing to the reduction of 
estrogen levels.
26
 
Since PCOS is one of the inflammatory 
response in the body, it is shown that ginger 
and its active components like 6-gingerol 
decrease the levels of proinflammatory 
cytokines (IL-1β, IL-6, TNFα).27 In addition, 
one of the anti-inflammatory effects of 
ginger and gingerol is inhibition of NF-kβ 
(Nuclear factor kappa β). NF-kβ is the most 
important factor in causing inflammation in 
the body that controls the production of 
other cytokines (TNFα, IL-1, IL-6), and 
important inducer of NF-kβ is oxidative 
stress.
28-30
 
 
CONCLUSION 
The present study is the first 
comparing the effects of 6-gingerol and 
ginger extract on recovery of PCOS. The 
results showed that 6-gingerol and ginger 
extract may be a useful treatment for 
improving the PCOS through reduction of 
estrogen, testosterone, LH and FSH, and 
improvement of ovulation. In fact, because 
of anti-inflammatory and antioxidant 
properties of ginger components, 
especially 6-gingerol, they can cause to 
improve PCOS. Their effects are dose 
dependent and the therapeutic potential of 
6-gingerol is more effective than the 
ginger extract. 
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